CZCai-Hua Zhang

Cai-Hua Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cai-Hua Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Du Li

    School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou 434023, China

    1 shared publication
  • Lingzhi Wang

    Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

    1 shared publication
  • Qian Jiang

    Department of Gastroenterology, First Affiliated Hospital of Yangtze University, Health Science Center, Yangtze University, Jingzhou 434023, China

    1 shared publication
  • Shunguang Chen

    Department of Orthopedics, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China

    1 shared publication
  • Xiao-Ping Tan

    Department of Gastroenterology, First Hospital of Yangtze University, Jingzhou of Hubei Province, China; Digestive Disease Research Institution of Yangtze University, Clinical Medical College, Yangtze University, Jingzhou of Hubei Province, China

    1 shared publication
  • Yu Xuan Liu

    Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore

    1 shared publication

Latest Publications

  • Open Access

    Non-Coding RNAs of Extracellular Vesicles: Key Players in Organ-Specific Metastasis and Clinical Implications

    by Qian Jiang, Xiao-Ping Tan, Cai-Hua Zhang, Zhi-Yuan Li, Du Li, Yan Xu, Yu Xuan Liu, Lingzhi Wang, Zhaowu Ma

    Extracellular vesicles (EVs) are heterogeneous membrane-encapsulated vesicles released by most cells. They act as multifunctional regulators of intercellular communication by delivering bioactive molecules, including non-coding RNAs (ncRNAs). Metastasis is a major cause of cancer-related death. Most cancer cells disseminate and colonize a specific target organ via EVs, a process known as “organ-specific metastasis”. Mounting evidence has shown that EVs are enriched with ncRNAs, and various EV-ncRNAs derived from tumor cells influence organ-specific metastasis via different mechanisms. Due to the tissue-specific expression of EV-ncRNAs, they could be used as potential biomarkers and therapeutic targets for the treatment of tumor metastasis in various types of cancer. In this review, we have discussed the underlying mechanisms of EV-delivered ncRNAs in the most common organ-specific metastases of liver, bone, lung, brain, and lymph nodes. Moreover, we summarize the potential clinical applications of EV-ncRNAs in organ-specific metastasis to fill the gap between benches and bedsides.